Similar Articles
Risk of flare in juvenile idiopathic arthritis: Is it related to the methotrexate treatment strategy or patient characteristics?
Rana İşgüder, Zehra Kızıldağ, Rüya Torun, Tuncay Aydın, Balahan Makay, Erbil Ünsal
DOI: 10.46497/ArchRheumatol.2023.10035
Issue: Volume 38 - Issue 4 - December 2023
1452
1040
Predictive risk factors for one-year mortality in idiopathic inflammatory myopathy patients with interstitial lung disease: A retrospective, single-center cohort study
Minna Jiang, Xiaohong Wen, Sisi Xia, Yiqun Guo, Yu Bai
DOI: 10.46497/ArchRheumatol.2024.10418
Issue: Volume 39 - Issue 2 - June 2024
1232
860
Pediatric to adult rheumatology transition: Success rates, influencing factors, and evolving diagnoses and treatments
Tuba Demirci Yıldırım, Rana İşgüder, Ezgi Karaçura, Yeşim Erez, Balahan Makay, Fatoş Önen, Şevket Erbil Ünsal, İsmail Sarı
DOI: 10.46497/ArchRheumatol.2024.10749
Issue: Volume 39 - Issue 4 - December 2024
713
503